Decision

Apotex v. Bristol-Myers Squibb Canada Co., 2019 FCA 194 (Apixaban*)

Justice Stratas; Justice Gauthier; Justice Laskin - 2019-06-27

Read full decision. Automatically generated summary:

This is an appeal by Apotex Inc. from an interlocutory order of Prothonotary Milczynski. The Prothonotary dismissed Apotex’s motion to compel answers to five questions the respondents objected to on discovery.

Decision relates to:

  • A-178-19 - APOTEX INC. v BRISTOL-MYERS SQUIBB CANADA CO. ET AL which is an appeal from a decision dated 2019-03-28 in T-350-18

 

Canadian Intellectual Property